Pharmacokinetics of oseltamivir among pregnant and nonpregnant women.

Am J Obstet Gynecol

Division of Reproductive Infectious Diseases, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Women's Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Published: June 2011

We sought to delineate the pharmacokinetics (PK) of oseltamivir and its active metabolite oseltamivir carboxylate during pregnancy. Physiologic changes of pregnancy, including increased renal filtration and secretion, may increase the clearance of oseltamivir carboxylate. Sixteen pregnant women taking oseltamivir for prophylaxis or treatment of suspected/proven influenza infection were enrolled. Twenty-three nonpregnant reproductive-age females served as the control group. The primary PK endpoint was area under the plasma concentration time curve for oseltamivir carboxylate. Pregnancy did not alter the PK parameters of the parent compound, oseltamivir. However, for oseltamivir carboxylate the area under the plasma concentration time curve was significantly lower (P = .007) and the apparent clearance significantly higher (P = .006) in pregnant women compared with nonpregnant women. Pregnancy produces lower systemic levels of oseltamivir carboxylate. Increasing the dose and/or dosing frequency of oseltamivir during pregnancy may be necessary to achieve comparable exposure in pregnant and nonpregnant women.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111757PMC
http://dx.doi.org/10.1016/j.ajog.2011.03.002DOI Listing

Publication Analysis

Top Keywords

oseltamivir carboxylate
20
nonpregnant women
12
oseltamivir
9
pharmacokinetics oseltamivir
8
pregnant nonpregnant
8
carboxylate pregnancy
8
pregnant women
8
area plasma
8
plasma concentration
8
concentration time
8

Similar Publications

Article Synopsis
  • * Edible bird's nest (EBN), which is swiftlet saliva consumed for health benefits, shows anti-avian viral properties, particularly by inhibiting the receptor-binding hemagglutinin (HA) activity after pancreatin treatment.
  • * EBN, rich in specific glycan structures, effectively enhances the action of antiviral drugs oseltamivir and zanamivir, suggesting its potential as a food-derived solution to combat avian viruses and reduce the risk of pandemics.
View Article and Find Full Text PDF
Article Synopsis
  • * The study evaluated the degradation behaviors of several anti-influenza drugs in urban rivers and a wastewater treatment plant, finding that newer drugs like BALM degrade quickly while older drugs persist in the environment.
  • * Ozonation after biological treatment was highly effective (over 90% removal) in eliminating anti-influenza drugs, highlighting its importance in managing pollution and reducing the risk of drug resistance in aquatic settings.
View Article and Find Full Text PDF

We present orally administrable prodrugs (s) of guanidino oseltamivir carboxylate () based on guanidine cyclic diimide (GCDI) to treat influenza viruses. By concealing the guanidine group, which significantly limits the intestinal absorption, its prodrugs s demonstrate dramatic improvement of oral bioavailability. The most promising antiviral substance readily forms covalent adducts with serum proteins via a degradable linker after the intestinal absorption.

View Article and Find Full Text PDF

Modulation of the transport-mediated active uptake by human serum albumin (HSA) for highly protein-bound substrates has been reported and improved the -to- extrapolation (IVIVE) of hepatic clearance. However, evidence for the relevance of such a phenomenon in the case of renal transporters is sparse. In this study, transport of renal organic anion transporter 1 or 3 (OAT1/3) substrates into conditionally immortalized proximal tubular epithelial cells transduced with OAT1/3 was measured in the presence and absence of 1 and 4% HSA while keeping the unbound substrate concentration constant (based on measured fraction unbound, ).

View Article and Find Full Text PDF

Citrus-derived flavanones as neuraminidase inhibitors: In vitro and in silico study.

Eur J Med Chem

November 2024

School of Food Science and Engineering, South China University of Technology, Guangzhou, 510640, PR China. Electronic address:

Neuraminidase (NA) has been well-studied as a therapeutic target for Influenza. However, resistance to the influenza virus has been observed recently. Out of special interest in the utilization of dietary antivirals from citrus, in vitro inhibition activity against NA and in silico studies including molecular docking, molecular dynamic simulation, and a predictive ADMET study, were performed on five citrus-derived flavanones.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!